The most significant indicators for MDS diagnosis were determined to be the ratio of granulocyte/lymphocyte SSC peak channels, total hematogone ratio, percentage of CD34+ B-cell progenitors among all CD34+ cells, and the percentage of CD34+ myeloid progenitors. The gene discussed is CD34; the disease is myelodysplastic syndrome.